Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2020 2
2021 8
2022 12
2023 9
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Neutralizing immunity against coronaviruses in Tanzanian health care workers.
Barabona G, Ngare I, Kamori D, Nkinda L, Kosugi Y, Mawazo A, Ekwabi R, Kinasa G, Chuwa H; Genotype to Phenotype Japan (G2P-Japan) Consortium; Sato K, Sunguya B, Ueno T. Barabona G, et al. Among authors: kosugi y. Sci Rep. 2024 Mar 6;14(1):5508. doi: 10.1038/s41598-024-55989-4. Sci Rep. 2024. PMID: 38448564 Free PMC article.
Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant.
Tamura T, Irie T, Deguchi S, Yajima H, Tsuda M, Nasser H, Mizuma K, Plianchaisuk A, Suzuki S, Uriu K, Begum MM, Shimizu R, Jonathan M, Suzuki R, Kondo T, Ito H, Kamiyama A, Yoshimatsu K, Shofa M, Hashimoto R, Anraku Y, Kimura KT, Kita S, Sasaki J, Sasaki-Tabata K, Maenaka K, Nao N, Wang L, Oda Y; Genotype to Phenotype Japan (G2P-Japan) Consortium; Ikeda T, Saito A, Matsuno K, Ito J, Tanaka S, Sato K, Hashiguchi T, Takayama K, Fukuhara T. Tamura T, et al. Nat Commun. 2024 Feb 8;15(1):1176. doi: 10.1038/s41467-024-45274-3. Nat Commun. 2024. PMID: 38332154 Free PMC article.
Virological characteristics of the SARS-CoV-2 BA.2.86 variant.
Tamura T, Mizuma K, Nasser H, Deguchi S, Padilla-Blanco M, Oda Y, Uriu K, Tolentino JEM, Tsujino S, Suzuki R, Kojima I, Nao N, Shimizu R, Wang L, Tsuda M, Jonathan M, Kosugi Y, Guo Z, Hinay AA Jr, Putri O, Kim Y, Tanaka YL, Asakura H, Nagashima M, Sadamasu K, Yoshimura K; Genotype to Phenotype Japan (G2P-Japan) Consortium; Saito A, Ito J, Irie T, Tanaka S, Zahradnik J, Ikeda T, Takayama K, Matsuno K, Fukuhara T, Sato K. Tamura T, et al. Among authors: kosugi y. Cell Host Microbe. 2024 Feb 14;32(2):170-180.e12. doi: 10.1016/j.chom.2024.01.001. Epub 2024 Jan 26. Cell Host Microbe. 2024. PMID: 38280382 Free article.
Characteristics of the SARS-CoV-2 omicron HK.3 variant harbouring the FLip substitution.
Kosugi Y, Plianchaisuk A, Putri O, Uriu K, Kaku Y, Hinay AA Jr, Chen L, Kuramochi J, Sadamasu K, Yoshimura K, Asakura H, Nagashima M, Ito J; Genotype to Phenotype Japan (G2P-Japan) Consortium; Sato K. Kosugi Y, et al. Lancet Microbe. 2024 Apr;5(4):e313. doi: 10.1016/S2666-5247(23)00373-7. Epub 2024 Jan 11. Lancet Microbe. 2024. PMID: 38219759 Free article. No abstract available.
Antiviral humoral immunity against SARS-CoV-2 omicron subvariants induced by XBB.1.5 monovalent vaccine in infection-naive and XBB-infected individuals.
Kosugi Y, Kaku Y, Hinay AA Jr, Guo Z, Uriu K, Kihara M, Saito F, Uwamino Y, Kuramochi J, Shirakawa K, Takaori-Kondo A; Genotype to Phenotype Japan (G2P-Japan) Consortium; Sato K. Kosugi Y, et al. Lancet Infect Dis. 2024 Mar;24(3):e147-e148. doi: 10.1016/S1473-3099(23)00784-3. Epub 2024 Jan 8. Lancet Infect Dis. 2024. PMID: 38211599 No abstract available.
Virological characteristics of the SARS-CoV-2 JN.1 variant.
Kaku Y, Okumura K, Padilla-Blanco M, Kosugi Y, Uriu K, Hinay AA Jr, Chen L, Plianchaisuk A, Kobiyama K, Ishii KJ; Genotype to Phenotype Japan (G2P-Japan) Consortium; Zahradnik J, Ito J, Sato K. Kaku Y, et al. Among authors: kosugi y. Lancet Infect Dis. 2024 Feb;24(2):e82. doi: 10.1016/S1473-3099(23)00813-7. Epub 2024 Jan 3. Lancet Infect Dis. 2024. PMID: 38184005 No abstract available.
Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics.
Kimura I, Yamasoba D, Nasser H, Ito H, Zahradnik J, Wu J, Fujita S, Uriu K, Sasaki J, Tamura T, Suzuki R, Deguchi S, Plianchaisuk A, Yoshimatsu K, Kazuma Y, Mitoma S, Schreiber G, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Takaori-Kondo A; Genotype to Phenotype Japan (G2P-Japan) Consortium; Ito J, Shirakawa K, Takayama K, Irie T, Hashiguchi T, Nakagawa S, Fukuhara T, Saito A, Ikeda T, Sato K. Kimura I, et al. J Virol. 2023 Oct 31;97(10):e0101123. doi: 10.1128/jvi.01011-23. Epub 2023 Oct 5. J Virol. 2023. PMID: 37796123 Free PMC article.
Transmissibility, infectivity, and immune evasion of the SARS-CoV-2 BA.2.86 variant.
Uriu K, Ito J, Kosugi Y, Tanaka YL, Mugita Y, Guo Z, Hinay AA Jr, Putri O, Kim Y, Shimizu R, Begum MM, Jonathan M; Genotype to Phenotype Japan (G2P-Japan) Consortium; Saito A, Ikeda T, Sato K. Uriu K, et al. Among authors: kosugi y. Lancet Infect Dis. 2023 Nov;23(11):e460-e461. doi: 10.1016/S1473-3099(23)00575-3. Epub 2023 Sep 18. Lancet Infect Dis. 2023. PMID: 37734391 No abstract available.
Antiviral efficacy of the SARS-CoV-2 XBB breakthrough infection sera against omicron subvariants including EG.5.
Kaku Y, Kosugi Y, Uriu K, Ito J, Hinay AA Jr, Kuramochi J, Sadamasu K, Yoshimura K, Asakura H, Nagashima M; Genotype to Phenotype Japan (G2P-Japan) Consortium; Sato K. Kaku Y, et al. Among authors: kosugi y. Lancet Infect Dis. 2023 Oct;23(10):e395-e396. doi: 10.1016/S1473-3099(23)00553-4. Epub 2023 Sep 11. Lancet Infect Dis. 2023. PMID: 37708910 No abstract available.
36 results